Sana Biotechnology, Inc.

NasdaqGS:SANA Stock Report

Market Cap: US$852.0m

Sana Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:SANA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Mar 24SellUS$236,300Patrick YangIndividual25,000US$9.45
08 Feb 24BuyUS$9,999,996Arch Venture Partners, L.P.Company1,818,181US$5.50

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SANA?
Owner TypeNumber of SharesOwnership Percentage
General Public6,295,9562.83%
Individual Insiders21,338,1169.59%
VC/PE Firms70,862,53731.9%
Institutions123,969,32555.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13%.


Top Shareholders

Top 25 shareholders own 88.4% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.6%
Arch Venture Partners, L.P.
45,860,681US$175.6m0%14.99%
11.2%
Flagship Pioneering, Inc
25,001,856US$95.8m0%19.6%
10%
FMR LLC
22,337,103US$85.6m29.8%0.01%
5.79%
The Vanguard Group, Inc.
12,878,680US$49.3m5.95%no data
4.97%
BlackRock, Inc.
11,045,448US$42.3m22.1%no data
4.75%
Baillie Gifford & Co.
10,571,200US$40.5m-0.8%0.02%
4.57%
Canada Pension Plan Investment Board
10,175,000US$39.0m0%0.03%
3.98%
Steven Harr
8,856,250US$33.9m0%no data
2.86%
State Street Global Advisors, Inc.
6,358,046US$24.4m-0.19%no data
2.64%
Capital Research and Management Company
5,881,106US$22.5m0%no data
2.6%
Hans Edgar Bishop
5,784,551US$22.2m0.08%no data
2.17%
Impresa Management LLC
4,832,423US$18.5m0%8.2%
2.1%
T. Rowe Price Group, Inc.
4,676,225US$17.9m-45%no data
1.45%
Crestline Investors Inc.
3,225,624US$12.4m-4.16%0.99%
1.3%
Geode Capital Management, LLC
2,890,425US$11.1m19.6%no data
1.26%
GV Management Company, LLC
2,812,500US$10.8m0%0.81%
1.21%
Richard Mulligan
2,698,121US$10.3m-10%no data
1.07%
Baker Bros. Advisors LP
2,380,949US$9.1m0%0.02%
0.7%
Sunil Agarwal
1,550,000US$5.9m0%no data
0.69%
Tavistock Life Sciences
1,545,000US$5.9m0%0.31%
0.64%
Morgan Stanley, Investment Banking and Brokerage Investments
1,427,554US$5.5m11.2%no data
0.54%
Integral Health Asset Management, LLC
1,200,000US$4.6m22.5%0.47%
0.42%
Charles Schwab Investment Management, Inc.
942,464US$3.6m14.4%no data
0.39%
JP Morgan Asset Management
867,901US$3.3m-14.7%no data
0.39%
Christian Hordo
867,455US$3.3m0%no data